International Clinical Trial: CannaRiver CBD Calm for Anxiety, Sleep, and Well-Being in Adults With Generalized Anxiety Disorder

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07821840) titled 'CannaRiver CBD Calm for Anxiety, Sleep, and Well-Being in Adults With Generalized Anxiety Disorder' on Sept. 10.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Associacão Pan-Americana Multidisciplinar de Endocanabinologia

Condition: Generalized Anxiety Disorder

Intervention: Drug: Cannabidiol (CBD) With Cannabinol (CBN) and Cannabigerol (CBG) Oral Tincture (CannaRiver CBD Calm)

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: November 1, 2026

Targe...